Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
22.07
+0.98 (4.65%)
Aug 1, 2025, 4:00 PM - Market closed
Chimerix Market Cap
Pacira BioSciences has a market cap or net worth of $1.02 billion as of August 1, 2025. Its market cap has increased by 4.60% in one year.
Market Cap
1.02B
Enterprise Value
1.16B
1-Year Change
4.60%
Ranking
Category
Stock Price
$22.07
Market Cap Chart
Since February 3, 2011, Pacira BioSciences's market cap has increased from $121.00M to $1.02B, an increase of 744.58%. That is a compound annual growth rate of 15.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.02B | 17.47% |
| Dec 31, 2024 | 869.90M | -44.48% |
| Dec 29, 2023 | 1.57B | -11.56% |
| Dec 30, 2022 | 1.77B | -33.90% |
| Dec 31, 2021 | 2.68B | 3.10% |
| Dec 31, 2020 | 2.60B | 37.52% |
| Dec 31, 2019 | 1.89B | 6.88% |
| Dec 31, 2018 | 1.77B | -4.50% |
| Dec 29, 2017 | 1.85B | 53.30% |
| Dec 30, 2016 | 1.21B | -57.20% |
| Dec 31, 2015 | 2.82B | -11.70% |
| Dec 31, 2014 | 3.20B | 65.79% |
| Dec 31, 2013 | 1.93B | 239.05% |
| Dec 31, 2012 | 568.70M | 281.68% |
| Dec 30, 2011 | 149.00M | 23.14% |
| Feb 3, 2011 | 121.00M | - |
View and export this data all the way back to 2011. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 688.20B |
| Johnson & Johnson | 404.67B |
| AbbVie | 336.99B |
| Novo Nordisk | 238.11B |
| UnitedHealth Group | 237.24B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.32B |
| Abbott Laboratories | 224.15B |